Rescuing emergency cases of COVID-19 patients: An intelligent real-time MSC transfusion framework based on multicriteria decision-making methods

Mesenchymal stem cells (MSCs) have shown promising ability to treat critical cases of coronavirus disease 2019 (COVID-19) by regenerating lung cells and reducing immune system overreaction. However, two main challenges need to be addressed first before MSCs can be efficiently transfused to the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsalem, M. A., Albahri, O. S., Zaidan, A. A., Al-Obaidi, Jameel R., Alnoor, Alhamzah, Alamoodi, A. H., Albahri, A. S., Zaidan, B. B., Jumaah, F. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741536/
https://www.ncbi.nlm.nih.gov/pubmed/35035091
http://dx.doi.org/10.1007/s10489-021-02813-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741536/
https://www.ncbi.nlm.nih.gov/pubmed/35035091
http://dx.doi.org/10.1007/s10489-021-02813-5

Ejemplares similares